BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Feng L, Cai L, He GL, Weng J, Li Y, Pan MX, Jiang ZS, Peng Q, Gao Y. Novel D-galactosamine-induced cynomolgus monkey model of acute liver failure. World J Gastroenterol 2017; 23(42): 7572-7583 [PMID: 29204057 DOI: 10.3748/wjg.v23.i42.7572] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Jin Y, Wang H, Yi K, Lv S, Hu H, Li M, Tao Y. Applications of Nanobiomaterials in the Therapy and Imaging of Acute Liver Failure. Nanomicro Lett 2020;13:25. [PMID: 34138224 DOI: 10.1007/s40820-020-00550-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
2 Li YT, Ye JZ, Lv LX, Xu H, Yang LY, Jiang XW, Wu WR, Shi D, Fang DQ, Bian XY, Wang KC, Wang QQ, Xie JJ, Lu YM, Li LJ. Pretreatment With Bacillus cereus Preserves Against D-Galactosamine-Induced Liver Injury in a Rat Model. Front Microbiol 2019;10:1751. [PMID: 31417535 DOI: 10.3389/fmicb.2019.01751] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
3 Huang YJ, Lee CY, Cao J, Lee HS, Chang CH, Chen PD, Wu YM. Therapeutic Potential of Plasma Proteins Derived from Umbilical Cord Blood for Acute Liver Failure. Mol Pharm 2019;16:1092-104. [PMID: 30698974 DOI: 10.1021/acs.molpharmaceut.8b01108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]